A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
Authors
Keywords
T cells, Spinal cord, Cytokines, Macrophages, Multiple sclerosis, Central nervous system, Cell cycle and cell division, Inflammatory diseases
Journal
PLoS One
Volume 9, Issue 4, Pages e94733
Publisher
Public Library of Science (PLoS)
Online
2014-04-12
DOI
10.1371/journal.pone.0094733
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation
- (2014) N. G. Innamorato et al. JOURNAL OF IMMUNOLOGY
- Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
- (2013) Francesca Borrelli et al. BIOCHEMICAL PHARMACOLOGY
- Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination
- (2013) Abdolmohamad Rostami et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Act1 mediates IL-17–induced EAE pathogenesis selectively in NG2+ glial cells
- (2013) Zizhen Kang et al. NATURE NEUROSCIENCE
- A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
- (2012) Aitor G. Granja et al. Journal of Neuroimmune Pharmacology
- Therapeutic Approach to Neurodegenerative Diseases by Medical Gases: Focusing on Redox Signaling and Related Antioxidant Enzymes
- (2012) Kyota Fujita et al. Oxidative Medicine and Cellular Longevity
- Phytocannabinoids as novel therapeutic agents in CNS disorders
- (2011) Andrew J. Hill et al. PHARMACOLOGY & THERAPEUTICS
- T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
- (2010) J. M. Fletcher et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice
- (2010) Diego Gomez-Nicola et al. EXPERIMENTAL NEUROLOGY
- Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens
- (2010) Koen Venken et al. JOURNAL OF NEUROIMMUNOLOGY
- Blood–brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE
- (2010) Jami Bennett et al. JOURNAL OF NEUROIMMUNOLOGY
- Axonal and neuronal pathology in multiple sclerosis: What have we learnt from animal models
- (2009) Hans Lassmann EXPERIMENTAL NEUROLOGY
- Cellular mechanisms of IL-17-induced blood-brain barrier disruption
- (2009) Jula Huppert et al. FASEB JOURNAL
- Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease
- (2009) S.E. O'Sullivan et al. IMMUNOBIOLOGY
- IL-17 Regulates CXCL1 mRNA Stability via an AUUUA/Tristetraprolin-Independent Sequence
- (2009) S. Datta et al. JOURNAL OF IMMUNOLOGY
- Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord
- (2009) K. A. Kigerl et al. JOURNAL OF NEUROSCIENCE
- The CB2Cannabinoid Receptor Controls Myeloid Progenitor Trafficking
- (2008) Javier Palazuelos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started